Page last updated: 2024-10-18

dihydroxyphenylalanine and 2019 Novel Coronavirus Disease

dihydroxyphenylalanine has been researched along with 2019 Novel Coronavirus Disease in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hu, T1
Agazani, O1
Nir, S1
Cohen, M1
Pan, S1
Reches, M1
Janeena, A1
Jayaraman, N1
Shanmugam, G1
Easwaramoorthi, S1
Ayyadurai, N1

Other Studies

2 other studies available for dihydroxyphenylalanine and 2019 Novel Coronavirus Disease

ArticleYear
Antiviral Activity of Peptide-Based Assemblies.
    ACS applied materials & interfaces, 2021, Oct-20, Volume: 13, Issue:41

    Topics: Animals; Antiviral Agents; Bacteriophages; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 D

2021
Electrochemical Response of Redox Amino Acid Encoded Fluorescence Protein for Hydroxychloroquine Sensing.
    Applied biochemistry and biotechnology, 2023, Volume: 195, Issue:2

    Topics: Amino Acids; COVID-19; COVID-19 Drug Treatment; Dihydroxyphenylalanine; Humans; Hydroxychloroquine;

2023